Report Overview
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
The global Intravenous Immunoglobulin (IVIg) market size was estimated at USD 10310 million in 2023 and is projected to reach USD 17271.19 million by 2032, exhibiting a CAGR of 5.90% during the forecast period.
North America Intravenous Immunoglobulin (IVIg) market size was estimated at USD 2965.08 million in 2023, at a CAGR of 5.06% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Intravenous Immunoglobulin (IVIg) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Intravenous Immunoglobulin (IVIg) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Intravenous Immunoglobulin (IVIg) market in any manner.
Global Intravenous Immunoglobulin (IVIg) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market Segmentation (by Type)
IVIg Liquid
IVIg Powder
Market Segmentation (by Application)
Immunodeficiency
Autoimmune Disease
Acute Infection
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Intravenous Immunoglobulin (IVIg) Market
Overview of the regional outlook of the Intravenous Immunoglobulin (IVIg) Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Intravenous Immunoglobulin (IVIg) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Intravenous Immunoglobulin (IVIg), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Intravenous Immunoglobulin (IVIg)
1.2 Key Market Segments
1.2.1 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.2 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Intravenous Immunoglobulin (IVIg) Market Overview
2.1 Global Market Overview
2.1.1 Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Intravenous Immunoglobulin (IVIg) Market Competitive Landscape
3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2019-2025)
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2019-2025)
3.3 Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Intravenous Immunoglobulin (IVIg) Sales Sites, Area Served, Product Type
3.6 Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
3.6.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
4.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Intravenous Immunoglobulin (IVIg) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Intravenous Immunoglobulin (IVIg) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2025)
6.3 Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Type (2019-2025)
6.4 Global Intravenous Immunoglobulin (IVIg) Price by Type (2019-2025)
7 Intravenous Immunoglobulin (IVIg) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Intravenous Immunoglobulin (IVIg) Market Sales by Application (2019-2025)
7.3 Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Application (2019-2025)
7.4 Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2019-2025)
8 Intravenous Immunoglobulin (IVIg) Market Consumption by Region
8.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region
8.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region
8.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region
8.2 North America
8.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Intravenous Immunoglobulin (IVIg) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Intravenous Immunoglobulin (IVIg) Market Production by Region
9.1 Global Production of Intravenous Immunoglobulin (IVIg) by Region (2019-2025)
9.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2019-2025)
9.3 Global Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Intravenous Immunoglobulin (IVIg) Production
9.4.1 North America Intravenous Immunoglobulin (IVIg) Production Growth Rate (2019-2025)
9.4.2 North America Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Intravenous Immunoglobulin (IVIg) Production
9.5.1 Europe Intravenous Immunoglobulin (IVIg) Production Growth Rate (2019-2025)
9.5.2 Europe Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Intravenous Immunoglobulin (IVIg) Production (2019-2025)
9.6.1 Japan Intravenous Immunoglobulin (IVIg) Production Growth Rate (2019-2025)
9.6.2 Japan Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Intravenous Immunoglobulin (IVIg) Production (2019-2025)
9.7.1 China Intravenous Immunoglobulin (IVIg) Production Growth Rate (2019-2025)
9.7.2 China Intravenous Immunoglobulin (IVIg) Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Baxter
10.1.1 Baxter Intravenous Immunoglobulin (IVIg) Basic Information
10.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Overview
10.1.3 Baxter Intravenous Immunoglobulin (IVIg) Product Market Performance
10.1.4 Baxter Business Overview
10.1.5 Baxter Intravenous Immunoglobulin (IVIg) SWOT Analysis
10.1.6 Baxter Recent Developments
10.2 Grifols
10.2.1 Grifols Intravenous Immunoglobulin (IVIg) Basic Information
10.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Overview
10.2.3 Grifols Intravenous Immunoglobulin (IVIg) Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols Intravenous Immunoglobulin (IVIg) SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 CSL
10.3.1 CSL Intravenous Immunoglobulin (IVIg) Basic Information
10.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Overview
10.3.3 CSL Intravenous Immunoglobulin (IVIg) Product Market Performance
10.3.4 CSL Intravenous Immunoglobulin (IVIg) SWOT Analysis
10.3.5 CSL Business Overview
10.3.6 CSL Recent Developments
10.4 Octapharma
10.4.1 Octapharma Intravenous Immunoglobulin (IVIg) Basic Information
10.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Overview
10.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Product Market Performance
10.4.4 Octapharma Business Overview
10.4.5 Octapharma Recent Developments
10.5 Biotest
10.5.1 Biotest Intravenous Immunoglobulin (IVIg) Basic Information
10.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Overview
10.5.3 Biotest Intravenous Immunoglobulin (IVIg) Product Market Performance
10.5.4 Biotest Business Overview
10.5.5 Biotest Recent Developments
10.6 Kedrion
10.6.1 Kedrion Intravenous Immunoglobulin (IVIg) Basic Information
10.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Overview
10.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Product Market Performance
10.6.4 Kedrion Business Overview
10.6.5 Kedrion Recent Developments
10.7 Hualan Bio
10.7.1 Hualan Bio Intravenous Immunoglobulin (IVIg) Basic Information
10.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Overview
10.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Market Performance
10.7.4 Hualan Bio Business Overview
10.7.5 Hualan Bio Recent Developments
10.8 CNBG
10.8.1 CNBG Intravenous Immunoglobulin (IVIg) Basic Information
10.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Overview
10.8.3 CNBG Intravenous Immunoglobulin (IVIg) Product Market Performance
10.8.4 CNBG Business Overview
10.8.5 CNBG Recent Developments
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Basic Information
10.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Overview
10.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Market Performance
10.9.4 Shanghai RAAS Business Overview
10.9.5 Shanghai RAAS Recent Developments
10.10 CBPO
10.10.1 CBPO Intravenous Immunoglobulin (IVIg) Basic Information
10.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Overview
10.10.3 CBPO Intravenous Immunoglobulin (IVIg) Product Market Performance
10.10.4 CBPO Business Overview
10.10.5 CBPO Recent Developments
10.11 LFB Group
10.11.1 LFB Group Intravenous Immunoglobulin (IVIg) Basic Information
10.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Overview
10.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Product Market Performance
10.11.4 LFB Group Business Overview
10.11.5 LFB Group Recent Developments
10.12 BPL
10.12.1 BPL Intravenous Immunoglobulin (IVIg) Basic Information
10.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Overview
10.12.3 BPL Intravenous Immunoglobulin (IVIg) Product Market Performance
10.12.4 BPL Business Overview
10.12.5 BPL Recent Developments
10.13 Sichuan Yuanda Shuyang
10.13.1 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Basic Information
10.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Overview
10.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Market Performance
10.13.4 Sichuan Yuanda Shuyang Business Overview
10.13.5 Sichuan Yuanda Shuyang Recent Developments
11 Intravenous Immunoglobulin (IVIg) Market Forecast by Region
11.1 Global Intravenous Immunoglobulin (IVIg) Market Size Forecast
11.2 Global Intravenous Immunoglobulin (IVIg) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country
11.2.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size Forecast by Region
11.2.4 South America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Type (2025-2032)
12.1.2 Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Intravenous Immunoglobulin (IVIg) by Type (2025-2032)
12.2 Global Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2025-2032)
12.2.1 Global Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Application
12.2.2 Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Intravenous Immunoglobulin (IVIg) Market Size Comparison by Region (M USD)
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2022)
Table 10. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Intravenous Immunoglobulin (IVIg) Sales Sites and Area Served
Table 12. Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
Table 13. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Intravenous Immunoglobulin (IVIg)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 22. Global Intravenous Immunoglobulin (IVIg) Sales by Type (K MT)
Table 23. Global Intravenous Immunoglobulin (IVIg) Market Size by Type (M USD)
Table 24. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) by Type (2019-2025)
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2025)
Table 26. Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) by Type (2019-2025)
Table 27. Global Intravenous Immunoglobulin (IVIg) Market Size Share by Type (2019-2025)
Table 28. Global Intravenous Immunoglobulin (IVIg) Price (USD/MT) by Type (2019-2025)
Table 29. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) by Application
Table 30. Global Intravenous Immunoglobulin (IVIg) Market Size by Application
Table 31. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2025) & (K MT)
Table 32. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2025)
Table 33. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2025) & (M USD)
Table 34. Global Intravenous Immunoglobulin (IVIg) Market Share by Application (2019-2025)
Table 35. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2019-2025)
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2025) & (K MT)
Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2019-2025)
Table 38. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2025) & (K MT)
Table 39. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2025) & (K MT)
Table 41. South America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Region (2019-2025) & (K MT)
Table 43. Global Intravenous Immunoglobulin (IVIg) Production (K MT) by Region (2019-2025)
Table 44. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2019-2025)
Table 46. Global Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Intravenous Immunoglobulin (IVIg) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Baxter Intravenous Immunoglobulin (IVIg) Basic Information
Table 52. Baxter Intravenous Immunoglobulin (IVIg) Product Overview
Table 53. Baxter Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Baxter Business Overview
Table 55. Baxter Intravenous Immunoglobulin (IVIg) SWOT Analysis
Table 56. Baxter Recent Developments
Table 57. Grifols Intravenous Immunoglobulin (IVIg) Basic Information
Table 58. Grifols Intravenous Immunoglobulin (IVIg) Product Overview
Table 59. Grifols Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Grifols Business Overview
Table 61. Grifols Intravenous Immunoglobulin (IVIg) SWOT Analysis
Table 62. Grifols Recent Developments
Table 63. CSL Intravenous Immunoglobulin (IVIg) Basic Information
Table 64. CSL Intravenous Immunoglobulin (IVIg) Product Overview
Table 65. CSL Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. CSL Intravenous Immunoglobulin (IVIg) SWOT Analysis
Table 67. CSL Business Overview
Table 68. CSL Recent Developments
Table 69. Octapharma Intravenous Immunoglobulin (IVIg) Basic Information
Table 70. Octapharma Intravenous Immunoglobulin (IVIg) Product Overview
Table 71. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Octapharma Business Overview
Table 73. Octapharma Recent Developments
Table 74. Biotest Intravenous Immunoglobulin (IVIg) Basic Information
Table 75. Biotest Intravenous Immunoglobulin (IVIg) Product Overview
Table 76. Biotest Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Biotest Business Overview
Table 78. Biotest Recent Developments
Table 79. Kedrion Intravenous Immunoglobulin (IVIg) Basic Information
Table 80. Kedrion Intravenous Immunoglobulin (IVIg) Product Overview
Table 81. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Kedrion Business Overview
Table 83. Kedrion Recent Developments
Table 84. Hualan Bio Intravenous Immunoglobulin (IVIg) Basic Information
Table 85. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Overview
Table 86. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Hualan Bio Business Overview
Table 88. Hualan Bio Recent Developments
Table 89. CNBG Intravenous Immunoglobulin (IVIg) Basic Information
Table 90. CNBG Intravenous Immunoglobulin (IVIg) Product Overview
Table 91. CNBG Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. CNBG Business Overview
Table 93. CNBG Recent Developments
Table 94. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Basic Information
Table 95. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Overview
Table 96. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Shanghai RAAS Business Overview
Table 98. Shanghai RAAS Recent Developments
Table 99. CBPO Intravenous Immunoglobulin (IVIg) Basic Information
Table 100. CBPO Intravenous Immunoglobulin (IVIg) Product Overview
Table 101. CBPO Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. CBPO Business Overview
Table 103. CBPO Recent Developments
Table 104. LFB Group Intravenous Immunoglobulin (IVIg) Basic Information
Table 105. LFB Group Intravenous Immunoglobulin (IVIg) Product Overview
Table 106. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. LFB Group Business Overview
Table 108. LFB Group Recent Developments
Table 109. BPL Intravenous Immunoglobulin (IVIg) Basic Information
Table 110. BPL Intravenous Immunoglobulin (IVIg) Product Overview
Table 111. BPL Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. BPL Business Overview
Table 113. BPL Recent Developments
Table 114. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Basic Information
Table 115. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Overview
Table 116. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Sichuan Yuanda Shuyang Business Overview
Table 118. Sichuan Yuanda Shuyang Recent Developments
Table 119. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Intravenous Immunoglobulin (IVIg) Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Intravenous Immunoglobulin (IVIg) Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Intravenous Immunoglobulin (IVIg) Market Size (M USD), 2019-2032
Figure 5. Global Intravenous Immunoglobulin (IVIg) Market Size (M USD) (2019-2032)
Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Intravenous Immunoglobulin (IVIg) Market Size by Country (M USD)
Figure 11. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2023
Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2023
Figure 13. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Intravenous Immunoglobulin (IVIg) Market Share by Type
Figure 18. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2019-2025)
Figure 19. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2023
Figure 20. Market Size Share of Intravenous Immunoglobulin (IVIg) by Type (2019-2025)
Figure 21. Market Size Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Intravenous Immunoglobulin (IVIg) Market Share by Application
Figure 24. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2025)
Figure 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2023
Figure 26. Global Intravenous Immunoglobulin (IVIg) Market Share by Application (2019-2025)
Figure 27. Global Intravenous Immunoglobulin (IVIg) Market Share by Application in 2023
Figure 28. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2019-2025)
Figure 30. North America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2023
Figure 32. U.S. Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Intravenous Immunoglobulin (IVIg) Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Intravenous Immunoglobulin (IVIg) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2023
Figure 37. Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2023
Figure 44. China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (K MT)
Figure 50. South America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2023
Figure 51. Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Intravenous Immunoglobulin (IVIg) Production Market Share by Region (2019-2025)
Figure 62. North America Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2019-2025)
Figure 65. China Intravenous Immunoglobulin (IVIg) Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Intravenous Immunoglobulin (IVIg) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2025-2032)
Figure 70. Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2025-2032)
Figure 71. Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2025-2032)
